摘要
2022年欧洲肿瘤内科学会(European Society for Medical Oncology,ESMO)年会于当地时间2022年9月9日在法国巴黎召开。本次大会报道了多项肝细胞癌(hepatocellular carcinoma,HCC)领域的重磅研究,涵盖晚期系统治疗、局部联合系统治疗和围手术期治疗等。这些研究结果将改变临床实践并推动肝癌领域的发展。本文重点介绍大会HCC相关研究结果,探讨HCC的治疗热点、问题和未来发展方向。
The 2022 annual meeting of the European Society of Medical Oncology(ESMO)was held on September 9th,2022 in Paris,France.This conference reported a number of important studies in the field of hepatocellular carcinoma(HCC),including advanced systemic therapy,local combination systemic therapy,perioperative therapy,etc.These results will change our clinical practice and promote the development of HCC.This article focuses on the HCC related research of the conference,and discusses the hot spots,problems and future development direction of HCC.
作者
成远
秦叔逵
Cheng Yuan;Qin Shukui(Cancer Center of PLA,General Hospital of the PLA Eastern Theater Command,Nanjing 210002,China)
出处
《实用肿瘤杂志》
CAS
2023年第1期5-10,共6页
Journal of Practical Oncology
关键词
肝细胞癌
欧洲肿瘤内科学会
2022
hepatocellular carcinoma
European Society of Medical Oncology
2022
